Indian units of global companies gain after GSK open offer
Reuters Market Eye - Shares in Indian units of global companies gain after GlaxoSmithKline Plc (GSK) (GSK.L) plans to raise its stake in its domestic unit GlaxoSmithKline Pharmaceuticals Ltd (GLAX.NS) via a $1 billion open offer.
Dealers say the open offer for GlaxoSmithKline Pharmaceuticals, which will be carried out at 26 percent above Friday's closing price, is raising hopes that other stake increases will also be carried out at similar premiums.
Among pharmaceutical units of global companies, Sanofi India Ltd (SANO.NS) gains 2.04 percent, Merck Ltd (MERK.NS) is up 5.62 percent, Abbott India Ltd (ABOT.NS) rises 2.49 percent, while Astrazeneca Pharma India Ltd (ASTR.NS) is 1.79 percent higher.
In other companies, Blue Dart Express Ltd (BLDT.NS) gains 1.11 percent, GlaxoSmithKline Consumer Healthcare Ltd (GLSM.NS) is up nearly 1 percent, while Nestle India Ltd (NEST.NS) rises 2.58 percent.
GlaxoSmithKline Pharmaceuticals shares surge 19 percent.
(Reporting by Abhishek Vishnoi)
- Tweet this
- Share this
- Digg this
- UPDATE 3-Turkish president rejects Facebook, YouTube ban over wiretaps
- Exclusive - Pimco's Gross declares El-Erian is 'trying to undermine me'
- UPDATE 1-"Everything is fine", Pistorius told guard after shooting girlfriend
- CEO in apparent suicide was bitcoin fan, had other issues, too
- Kejriwal takes aim at Modi's economic model
Sahara’s investment programmes include schemes that are similar to a typical Indian bank’s fixed or recurring deposits. But the arrest of the company's chief Subrata Roy last week and the court case over an outlawed bond scheme are raising fears among some investors who worry they will not get their money back. Full Article